Cleared Traditional

K222932 - INVOcell Intravaginal Culture System (FDA 510(k) Clearance)

Jun 2023
Decision
269d
Days
Class 2
Risk

K222932 is an FDA 510(k) clearance for the INVOcell Intravaginal Culture System. This device is classified as a Culture, Intravaginal, Assisted Reproduction (Class II - Special Controls, product code OYO).

Submitted by Invo Bioscience (Sarasota, US). The FDA issued a Cleared decision on June 22, 2023, 269 days after receiving the submission on September 26, 2022.

This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 884.6165. Intravaginal Culture Of Human Gametes And Embryos. To Hold And Maintain Gametes And Developing Embryos Over The Duration Of The Intravaginal Culture Period..

Submission Details

510(k) Number K222932 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2022
Decision Date June 22, 2023
Days to Decision 269 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code OYO - Culture, Intravaginal, Assisted Reproduction
Device Class Class II - Special Controls
CFR Regulation 21 CFR 884.6165
Definition Intravaginal Culture Of Human Gametes And Embryos. To Hold And Maintain Gametes And Developing Embryos Over The Duration Of The Intravaginal Culture Period.